Methods of treating arthritis and diabetic retinopathy with αvβ3-specific antibodies
US7354586B2 · kind B2 · utility
8Cited by
18References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2004 |
| Grant date | Apr 8, 2008 |
| Priority date | — |
| Expiry date | Jul 26, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention describes methods for inhibition angiogenesis in tissues using vitronectin αvβ3 antagonists, and particularly for inhibiting angiogenesis in inflamed tissues and in tumor tissues and metastases using therapeutic compositions containing αvβ3 antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.